Objective: To determine whether trigonelline contributes to the effect of coffee on homocysteine (Hcy). Design and interventions: This was a randomised crossover study. Subjects consumed 50 mg trigonelline, 5 g of instant coffee (E50 mg trigonelline) or water, consumed as a single dose in 100 ml, with 1 week between each treatment. Blood samples were drawn fasting and hourly for 8 h. Urine samples were collected pretreatment and every 2 h for 8 h. Setting: Christchurch Clinical Studies Trust, Christchurch, New Zealand. Subjects: Eight healthy male subjects. Results: Instant coffee raised plasma Hcy concentrations compared with water (P ¼ 0.019) and trigonelline (P ¼ 0.037). Plasma Hcy concentrations were not different between water and trigonelline treatments (P ¼ 0.789). The change in plasma Hcy concentration was higher (mean7s.e.) 4 h (0.770.2 mmol/l, P ¼ 0.006), 5 h (0.770.2 mmol/l, P ¼ 0.013) and 7 h (0.770.2 mmol/l, P ¼ 0.024) following coffee consumption. Urinary glycine betaine excretion was increased by coffee but not by trigonelline.
Introduction
Elevated plasma homocysteine (Hcy) concentrations are associated with an increased risk of vascular disease (Boushey et al, 1995; Welch & Loscalzo, 1998) and foetal birth defects (Vollset et al, 2000) . Coffee consumption correlates with plasma Hcy concentration (Nygård et al, 1997; StolzenbergSolomon et al, 1999) . Filtered (Urgert et al, 2000) and unfiltered coffee (Grubben et al, 2000) increase plasma Hcy concentration by approximately 10%, while abstention from filtered coffee reduces plasma Hcy concentration (Christensen et al, 2001) . Caffeine contributes part of the effect of coffee on Hcy (Verhoef et al, 2002) . Another possibility is that components of coffee could inhibit the methylation of Hcy by betaine, catalysed by betaine-homocysteine methyltransferase (BHMT-E.C. 2.1.1.5, Malinow, 1994) . Trigonelline, a natural constituent of coffee (approximately 1% dry matter in roasted coffee beans, (Wu et al, 1997) is an analogue of glycine betaine that may competitively inhibit BHMT.
Subjects and methods
The Canterbury Ethics Committee approved the protocol. Eight male subjects (21-38 y) gave informed consent. Subjects normally consumed coffee, had normal plasma Hcy (5-15 mmol/l), folate, vitamin B 12 and haemoglobin concentra-tions, were not using vitamin B supplements, were nonsmokers and were in good health based on medical history and physical examination.
A Latin-square design was used with three treatments in random order: 50 mg trigonelline, 5 g instant coffee (containing E50 mg trigonelline by analysis) and water. The trial was conducted over three consecutive weeks, with 1 day per week the treatment day and the rest of the week a wash-out period. Each treatment day, subjects consumed one treatment as a single dose in 100 ml volume. Subjects were asked to abstain from coffee and foods known to be high in trigonelline (de Zwart et al, 2003) for 2 days, and fasted 12 h, prior to treatment.
Fasting venous blood samples were drawn through an indwelling catheter into EDTA tubes. Following treatment, samples were collected every hour, and urine samples every 2 h, for 8 h. The subjects consumed a standard breakfast (1 and 2 h) and a standard lunch (4 and 5 h). The diet and the amount consumed was the same for the three treatment days, with food low in both trigonelline and glycine betaine (de Zwart et al, 2003) . Each subject consumed 150 ml of water following each blood sample collection. After 8 h, subjects collected an 8-24 h urine sample, which was returned the following morning, and a 24-h blood sample was obtained.
Plasma was separated by centrifugation at 2000 Â g for 10 min and urine sample volume was recorded and a 10 ml aliquot was removed. All samples were stored at À201C until analysis.
Plasma Hcy measurements were carried out by a fluorescence polarization immunoassay (Abbott Imx s Analyser). Plasma glycine betaine, trigonelline and urine glycine betaine were measured by HPLC, and urine concentrations of dimethylglycine and trigonelline by 1 H-NMR, as previously described (Slow et al, in press ). Urine creatinine was measured by the Jaffé reaction (Murray, 1984) , and urine betaine excretion calculated as a ratio to creatinine.
Differences in plasma concentrations of Hcy, glycine betaine, trigonelline, and urine glycine betaine, trigonelline and dimethylglycine, between pretreatment and post-treatment concentrations were calculated for each subject for each treatment day. Treatment effects were first studied using repeated measures analysis of variance (ANOVA). If the ANOVA indicated an overall treatment effect (Pr0.05), the treatment means were compared using Fishers' protected LSD test at each time point. An incremental area under the curve analysis, paired between treatments, was also conducted for the plasma Hcy results using all data between 0 and 8 h.
Results
For treatment days 1, 2 and 3, the mean (7s. e.) baseline plasma Hcy concentrations were 8.070.2, 7.870.2, and 7.870.2 mmol/l. Plasma Hcy concentrations were significantly higher following coffee consumption compared with water (P ¼ 0.019) and trigonelline (P ¼ 0.037), between 1 and 8 h after treatment (Figure 1 ). There was no significant difference in plasma Hcy concentration between water and trigonelline (P ¼ 0.789). Compared with water the mean change in plasma Hcy concentration was significantly higher 4 h (P ¼ 0.006), 5 h (P ¼ 0.013) and 7 h (P ¼ 0.024) following coffee consumption (Figure 1) .
The mean (7s.e.) baseline plasma glycine betaine were 41.274.4, 41.973.7 and 43.175.7 mmol/l. Plasma glycine betaine concentrations were significantly higher 1 h following trigonelline treatment compared with water (P ¼ 0.035) and coffee (P ¼ 0.040). This effect disappeared within 2 h of trigonelline consumption. There was no significant difference in plasma glycine betaine concentration between coffee and water (P ¼ 0.716).
The mean baseline (7s.e.) urinary excretions of glycine betaine were 3.870.7, 7.171.0 and 5.070.7 mmol/mol creatinine. Following coffee consumption, the urinary excretion of glycine betaine increased by 7.370.9 mmol/ mol creatinine at 2 h and 8.870.9 mmol/mol creatinine at 4 h, and was significantly higher compared with water and trigonelline treatment (Figure 2a) . Compared with water, Figure 1 Effect of treatment on plasma homocysteine concentration. Data are expressed as mean change7s.e.m. (mmol/l): coffee treatment trigonelline treatment ; and water treatment . Significant differences indicated by *, Pp0.05, Fishers' protected LSD test paired between treatments, n ¼ 8.
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S Slow et al urinary glycine betaine was significantly lower 4 h following trigonelline treatment (Figure 2a) . The mean baseline (7s.e.) urinary excretions of trigonelline were 6.571.8, 5.270.8 and 6.070.8 mmol/mol creatinine, respectively. There was no significant difference in urinary trigonelline between coffee and trigonelline treatment (Figure 2b ). There was no significant difference in the urinary dimethylglycine excretions between any of the treatments.
Discussion
In healthy subjects, a single dose of strong instant coffee acutely increased plasma Hcy concentrations by approximately 10%. This confirms and extends previous findings, where plasma Hcy significantly increased following consumption of filtered (Urgert et al, 2000; Verhoef et al, 2002) and unfiltered (Grubben et al, 2000) coffee. Plasma Hcy increased 0.7 mmol/l 4 h following instant coffee consumption and remained significantly elevated for 7 h compared with placebo, which is consistent with Verhoef et al (2002) . Trigonelline, a glycine betaine analogue found in coffee (Mazzafera, 1991; Stennert & Maier, 1994; Wu et al, 1997) , is not responsible for this increase in Hcy as there was no significant difference in plasma Hcy concentration between trigonelline and water treatment.
Although there was no evidence that trigonelline inhibits BHMT activity, urine glycine betaine was elevated between 2 and 4 h following coffee consumption (Figure 2a ). This may be associated with the decrease in plasma glycine betaine concentration following coffee consumption compared with an equivalent dose of trigonelline alone. Hcy methylation via the BHMT pathway may be impaired as a result of lower methyl donor availability, contributing to an increase in plasma Hcy by coffee. Caffeine contributes approximately half of the Hcy raising effect of coffee (Verhoef et al, 2002) , and chlorogenic acid (Olthof et al, 2001 ) is another component that raises Hcy. The effect of coffee on Hcy may be a combination of factors with varied mechanisms. 
